PMCB

PharmaCyte Biotech, Inc.

Price Chart

No historical data available

Latest Quote

$0.52

-0.02 (-3.09%)

Current Price

Previous Close	$0.54
Open	$0.53
Day High	$0.53
Day Low	$0.52
Volume	68,495

Fetched: 2026-08-28T18:31:54

Stock Information

Shares Outstanding	10.74M
Cash Equivalents	$37.08M
Net Income	$-23.21M
Sector	Healthcare
Industry	Biotechnology
Market Cap	$5.53M
EPS (TTM)	$-2.77
Exchange	NCM

🌐 Visit Website

Recent Price History

No history data available. Data will be fetched automatically.

About PharmaCyte Biotech, Inc.

PharmaCyte Biotech, Inc., a biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States. The company's cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer. It also develops CypCaps for pancreatic cancer and other solid cancerous tumors. It has a cooperation agreement with Iroquois Master Fund Ltd.; license agreements with SG Austria Pte. Ltd.; and Austrianova Singapore Pte. Ltd. to use the Cell-in-the-Box technology for cancer treatment. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.

📰 Latest News

No news articles available at the moment. Check back later for updates on PMCB.

Period:

Income Statement (Annual)

Metric	2026-04-30	2025-04-30	2024-04-30	2023-04-30
Revenue
Total Revenue	$0	$0	$0	$0
Operating Revenue	$0	$0	$0	$0
Expenses
Total Expenses	$5,304,286	$4,377,862	$6,520,008	$6,455,494
Other Income Expense	$-14,853,719	$33,618,351	$3,454,952	$202,002
Other Non Operating Income Expenses	$-1,450,533	$-965	$191,145	$202,002
Net Non Operating Interest Income Expense	$733,351	$1,415,561	$3,398,819	$1,937,499
Operating Expense	$5,304,286	$4,377,862	$6,520,008	$6,455,494
General And Administrative Expense	$4,912,985	$3,939,446	$6,112,577	$4,752,002
Other Operating Expenses	-	-	$1,322,414	$1,234,956
Interest Expense	-	-	-	$0
Interest Expense Non Operating	-	-	-	$0
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$-19,424,654	$30,656,050	$333,763	$-4,315,993
Net Interest Income	$733,351	$1,415,561	$3,398,819	$1,937,499
Interest Income	$733,351	$1,415,561	$3,398,819	$1,937,499
Normalized Income	$-6,021,468	$-2,963,266	$-2,244,645	$-4,315,993
Net Income From Continuing And Discontinued Operation	$-19,424,654	$30,656,050	$333,763	$-4,315,993
Total Operating Income As Reported	$-6,853,713	$-4,377,862	$-8,520,008	$-6,455,494
Net Income Common Stockholders	$-23,206,372	$23,362,107	$-17,237,403	$-4,315,993
Net Income	$-19,424,654	$30,656,050	$333,763	$-4,315,993
Net Income Including Noncontrolling Interests	$-19,424,654	$30,656,050	$333,763	$-4,315,993
Net Income Continuous Operations	$-19,424,654	$30,656,050	$333,763	$-4,315,993
Pretax Income	$-19,424,654	$30,656,050	$333,763	$-4,315,993
Special Income Charges	$-1,443,427	$-2,019,000	$-3,572,193	$0
Interest Income Non Operating	$733,351	$1,415,561	$3,398,819	$1,937,499
Operating Income	$-5,304,286	$-4,377,862	$-6,520,008	$-6,455,494
Per Share
Diluted EPS	-	$3.19	$-1.80	$-0.22
Basic EPS	-	$3.19	$-1.80	$-0.22
Other
Tax Effect Of Unusual Items	$0	$0	$685,399	$0
Tax Rate For Calcs	$0	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$8,098,900	$-37,997,178	$-9,783,815	$-6,455,494
Total Unusual Items	$-13,403,186	$33,619,316	$3,263,807	$0
Total Unusual Items Excluding Goodwill	$-13,403,186	$33,619,316	$3,263,807	$0
EBITDA (Bullshit earnings)	$-5,304,286	$-4,377,862	$-6,520,008	$-6,455,494
EBIT	$-5,304,286	$-4,377,862	$-6,520,008	$-6,455,494
Diluted NI Availto Com Stockholders	$-23,206,372	$23,362,107	$-17,237,403	$-4,315,993
Otherunder Preferred Stock Dividend	$3,503,222	$6,164,184	$15,053,521	$0
Preferred Stock Dividends	$278,496	$1,129,759	$2,517,645	-
Tax Provision	$0	$0	-	-
Other Special Charges	$-106,000	$2,019,000	-	-
Impairment Of Capital Assets	$1,549,427	$0	$2,000,000	$0
Gain On Sale Of Security	$-11,959,759	$35,638,316	$6,836,000	-
Research And Development	$391,301	$438,416	$407,431	$468,536
Selling General And Administration	$4,912,985	$3,939,446	$6,112,577	$4,752,002
Other Gand A	$4,912,985	$3,939,446	$6,112,577	$3,800,655
Diluted Average Shares	-	$7,329,596	$9,581,059	$19,489,204
Basic Average Shares	-	$7,329,596	$9,581,059	$19,489,204
Gain On Sale Of Ppe	-	$0	$-1,572,193	$0
Write Off	-	-	$1,572,193	$0
Salaries And Wages	-	-	$1,141,215	$951,347

Fetched: 2026-08-28

Balance Sheet (Annual)

Metric	2026-04-30	2025-04-30	2024-04-30	2023-04-30
Assets
Net Tangible Assets	$34,980,818	$50,341,642	$37,965,192	$69,140,917
Total Assets	$46,753,242	$55,168,353	$59,903,883	$73,276,925
Total Non Current Assets	$9,332,688	$32,793,115	$9,464,115	$5,129,308
Other Non Current Assets	$7,688	$7,688	$7,688	$7,688
Financial Assets	$9,325,000	$8,762,000	$5,152,000	$0
Goodwill And Other Intangible Assets	$0	$1,549,427	$1,549,427	$3,549,427
Current Assets	$37,420,554	$22,375,238	$50,439,768	$68,147,617
Other Current Assets	$96,879	$223,759	$259,800	$107,681
Hedging Assets Current	$0	$2,917,000	$0	-
Receivables	$240,766	$3,696,000	$0	-
Other Receivables	$240,766	-	-	-
Notes Receivable	$0	$3,696,000	$0	-
Cash Cash Equivalents And Short Term Investments	$37,082,909	$15,538,479	$50,179,968	$68,039,936
Cash And Cash Equivalents	$18,603,899	$15,172,163	$50,179,968	$68,039,936
Non Current Note Receivables	-	$0	$2,755,000	$0
Other Intangible Assets	-	$1,549,427	$1,549,427	$3,549,427
Prepaid Assets	-	-	-	$107,681
Cash Financial	-	-	-	-
Liabilities
Total Liabilities Net Minority Interest	$11,772,424	$3,277,284	$20,389,264	$586,581
Total Non Current Liabilities Net Minority Interest	$10,946,000	$363,000	$12,968,000	$0
Derivative Product Liabilities	$10,946,000	$338,000	$12,968,000	$0
Current Liabilities	$826,424	$2,914,284	$7,421,264	$586,581
Payables And Accrued Expenses	$826,424	$2,914,284	$1,124,568	$586,581
Payables	$271,102	$424,628	$729,441	$186,377
Total Tax Payable	$0	$25,424	$340,072	$58,096
Accounts Payable	$271,102	$399,204	$389,369	$128,281
Other Current Liabilities	-	-	$6,296,696	-
Equity
Common Stock Equity	$33,711,926	$51,891,069	$27,647,603	$72,690,344
Preferred Stock Equity	$1,268,892	-	$11,867,016	-
Total Equity Gross Minority Interest	$34,980,818	$51,891,069	$39,514,619	$72,690,344
Stockholders Equity	$34,980,818	$51,891,069	$39,514,619	$72,690,344
Other Equity Interest	$417,000	-	-	-
Gains Losses Not Affecting Retained Earnings	$-20,796	$-23,869	$-23,511	$-23,003
Other Equity Adjustments	$-20,796	$-23,869	$-23,511	$-23,003
Retained Earnings	$-104,393,614	$-84,968,960	$-115,625,010	$-115,958,773
Other
Ordinary Shares Number	$10,735,649	$6,795,779	$8,037,624	$16,793,980
Share Issued	$10,735,649	$21,672,095	$21,672,078	$21,602,078
Tangible Book Value	$33,711,926	$50,341,642	$26,098,176	$69,140,917
Invested Capital	$33,711,926	$51,891,069	$27,647,603	$72,690,344
Working Capital	$36,594,130	$19,460,954	$43,018,504	$67,561,036
Total Capitalization	$34,980,818	$51,891,069	$39,514,619	$72,690,344
Treasury Stock	$45,009,541	$44,607,916	$42,040,216	$13,560,623
Additional Paid In Capital	$182,716,275	$181,489,647	$185,334,173	$202,230,583
Capital Stock	$1,271,494	$2,167	$11,869,183	$2,160
Common Stock	$2,602	$2,167	$2,167	$2,160
Preferred Stock	$1,268,892	$0	$11,867,016	$0
Non Current Accrued Expenses	$0	$25,000	$0	-
Current Accrued Expenses	$555,322	$2,489,656	$395,127	$400,204
Investments And Advances	$0	$22,474,000	$0	$1,572,193
Other Short Term Investments	$18,479,010	$366,316	$0	-
Treasury Shares Number	-	$14,876,316	$13,634,454	$4,808,098

Fetched: 2026-08-28

Cash Flow Statement (Annual)

Metric	2026-04-30	2025-04-30	2024-04-30	2023-04-30
Free Cash Flow
Free Cash Flow	$-5,152,914	$-2,978,296	$-2,151,457	$-3,793,731
Operating Activities
Operating Cash Flow	$-5,152,914	$-2,978,296	$-2,151,457	$-3,793,731
Cash Flow From Continuing Operating Activities	$-5,152,914	$-2,978,296	$-2,151,457	$-3,793,731
Operating Gains Losses	$7,483,135	$-8,171,316	$-4,174,807	-
Investing Activities
Investing Cash Flow	$2,000,000	$-7,000,000	$-5,000,000	$0
Cash Flow From Continuing Investing Activities	$2,000,000	$-7,000,000	$-5,000,000	$0
Net Other Investing Changes	$5,000,000	-	$-5,000,000	-
Financing Activities
Repurchase Of Capital Stock	$-401,625	$-25,029,151	$-44,358,148	$-13,560,623
Issuance Of Capital Stock	$6,182,447	$0	$33,650,075	$0
Financing Cash Flow	$6,581,577	$-25,029,151	$-10,708,003	$-13,559,743
Cash Flow From Continuing Financing Activities	$6,581,577	$-25,029,151	$-10,708,003	$-13,559,743
Cash Dividends Paid	$-246,005	$0	-	-
Preferred Stock Dividend Paid	$-246,005	$0	-	-
Net Preferred Stock Issuance	$6,182,447	$-22,486,875	$17,489,544	$0
Preferred Stock Issuance	$6,182,447	$0	$33,650,075	$0
Net Common Stock Issuance	$-401,625	$-2,542,276	$-28,197,617	$-13,560,623
Common Stock Issuance	-	-	-	$0
Other
Income Tax Paid Supplemental Data	$0	$0	$1,600	$0
End Cash Position	$18,603,899	$15,172,163	$50,179,968	$68,039,936
Beginning Cash Position	$15,172,163	$50,179,968	$68,039,936	$85,400,656
Effect Of Exchange Rate Changes	$3,073	$-358	$-508	$-7,246
Changes In Cash	$3,428,663	$-35,007,447	$-17,859,460	$-17,353,474
Proceeds From Stock Option Exercised	$1,046,760	$0	$70	$880
Preferred Stock Payments	$0	$-22,486,875	$-16,160,531	$0
Common Stock Payments	$-401,625	$-2,542,276	$-28,197,617	$-13,560,623
Net Investment Purchase And Sale	$-3,000,000	$-7,000,000	$0	$0
Purchase Of Investment	$-3,000,000	$-7,000,000	$0	-
Change In Working Capital	$-1,927,737	$1,356,333	$298,894	$-297,166
Change In Payables And Accrued Expense	$-1,676,351	$1,320,292	$451,013	$-283,657
Change In Accrued Expense	$-1,548,249	$1,310,457	$189,923	$-40,709
Change In Payable	$-128,102	$9,835	$261,090	$-242,948
Change In Account Payable	$-128,102	$9,835	$261,090	$-242,948
Change In Prepaid Assets	$-251,386	$36,041	$-152,119	$-13,509
Other Non Cash Items	$-801,947	$-21,226,734	$-195,000	$174,022
Stock Based Compensation	$1,128,556	$478,637	$674,693	$645,406
Unrealized Gain Loss On Investment Securities	$6,840,306	$-6,071,266	$-1,089,000	$0
Asset Impairment Charge	$1,549,427	$0	$2,000,000	$0
Gain Loss On Investment Securities	$7,483,135	$-8,171,316	$-5,747,000	-
Net Income From Continuing Operations	$-19,424,654	$30,656,050	$333,763	$-4,315,993
Repayment Of Debt	-	-	-	$0
Interest Paid Supplemental Data	-	-	-	$0
Net Issuance Payments Of Debt	-	-	-	$0
Net Long Term Debt Issuance	-	-	-	$0
Long Term Debt Payments	-	-	-	$0
Change In Other Current Assets	-	-	-	$0

Fetched: 2026-08-28